Skip to content
OpenCapital
Get started

Agilon Health AGL Cash & Equivalents

Cash & Equivalents at other companies

CVS Health logo
CVS HealthCVS
$9.77B-5.6%
Astrana Health logo
Astrana HealthASTH
$478.38M+85.0%
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
$419.52M-10.6%
Alignment Healthcare logo
Alignment HealthcareALHC
$707.71M+57.9%
Clover Health Investments logo
Clover Health InvestmentsCLOV
$173.27M+11.5%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$197.66M+234%

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.86B-92.6%
Enterprise value$1.69B-103%
P/S0.3×-3.9×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%—

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio1×-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's cash & equivalents?
Agilon Health (AGL) reported cash & equivalents of $211.57M in Q1 2026.
How has Agilon Health's cash & equivalents changed year-over-year?
Agilon Health's cash & equivalents increased by 52.6% year-over-year, from $138.62M to $211.57M.
What is the long-term trend for Agilon Health's cash & equivalents?
Over 5 years (2020 to 2025), Agilon Health's cash & equivalents has grown at a 10.2% compound annual growth rate (CAGR), from $106.8M to $173.71M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.